Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 2
1969 3
1970 1
1971 4
1973 5
1974 3
1975 2
1976 5
1977 2
1978 1
1979 1
1980 3
1981 4
1982 2
1983 6
1984 2
1985 5
1986 5
1987 5
1988 7
1989 9
1990 3
1991 2
1992 7
1993 4
1994 1
1995 3
1996 4
1997 3
1998 4
1999 13
2000 9
2001 5
2002 7
2003 9
2004 5
2005 4
2006 6
2007 7
2008 4
2009 3
2010 3
2011 13
2012 16
2013 12
2014 14
2015 18
2016 27
2017 24
2018 16
2019 16
2020 21
2021 23
2022 26
2023 19
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

395 results

Results by year

Filters applied: . Clear all
Page 1
CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment.
Fujiwara T, Yakoub MA, Chandler A, Christ AB, Yang G, Ouerfelli O, Rajasekhar VK, Yoshida A, Kondo H, Hata T, Tazawa H, Dogan Y, Moore MAS, Fujiwara T, Ozaki T, Purdue E, Healey JH. Fujiwara T, et al. Among authors: tazawa h. Mol Cancer Ther. 2021 Aug;20(8):1388-1399. doi: 10.1158/1535-7163.MCT-20-0591. Epub 2021 Jun 4. Mol Cancer Ther. 2021. PMID: 34088832 Free PMC article.
Dual antiplatelet therapy inhibits neutrophil extracellular traps to reduce liver micrometastases of intrahepatic cholangiocarcinoma.
Yoshimoto M, Kagawa S, Kajioka H, Taniguchi A, Kuroda S, Kikuchi S, Kakiuchi Y, Yagi T, Nogi S, Teraishi F, Shigeyasu K, Yoshida R, Umeda Y, Noma K, Tazawa H, Fujiwara T. Yoshimoto M, et al. Among authors: tazawa h. Cancer Lett. 2023 Jul 28;567:216260. doi: 10.1016/j.canlet.2023.216260. Epub 2023 Jun 7. Cancer Lett. 2023. PMID: 37295551
Role of Tumor-Associated Macrophages in Sarcomas.
Fujiwara T, Healey J, Ogura K, Yoshida A, Kondo H, Hata T, Kure M, Tazawa H, Nakata E, Kunisada T, Fujiwara T, Ozaki T. Fujiwara T, et al. Among authors: tazawa h. Cancers (Basel). 2021 Mar 3;13(5):1086. doi: 10.3390/cancers13051086. Cancers (Basel). 2021. PMID: 33802565 Free PMC article. Review.
p53 Replacement Therapy for Cancer.
Tazawa H, Kagawa S, Fujiwara T. Tazawa H, et al. Recent Results Cancer Res. 2016;209:1-15. doi: 10.1007/978-3-319-42934-2_1. Recent Results Cancer Res. 2016. PMID: 28101684 Review.
Overcoming cancer-associated fibroblast-induced immunosuppression by anti-interleukin-6 receptor antibody.
Nishiwaki N, Noma K, Ohara T, Kunitomo T, Kawasaki K, Akai M, Kobayashi T, Narusaka T, Kashima H, Sato H, Komoto S, Kato T, Maeda N, Kikuchi S, Tanabe S, Tazawa H, Shirakawa Y, Fujiwara T. Nishiwaki N, et al. Among authors: tazawa h. Cancer Immunol Immunother. 2023 Jul;72(7):2029-2044. doi: 10.1007/s00262-023-03378-7. Epub 2023 Feb 10. Cancer Immunol Immunother. 2023. PMID: 36764954 Free PMC article.
RNA Editing is a Valuable Biomarker for Predicting Carcinogenesis in Ulcerative Colitis.
Takahashi K, Shigeyasu K, Kondo Y, Gotoh K, Yano S, Umeda Y, Inokuchi T, Xu C, Yoshida K, Umeda H, Takahashi T, Takeda S, Yoshida R, Teraishi F, Kishimoto H, Mori Y, Noma K, Okugawa Y, Hiraoka S, Michiue H, Tazawa H, Matsushita O, Goel A, Fujiwara T. Takahashi K, et al. Among authors: tazawa h. J Crohns Colitis. 2023 May 3;17(5):754-766. doi: 10.1093/ecco-jcc/jjac186. J Crohns Colitis. 2023. PMID: 36528792 Free article.
395 results